Drugs / Reproxalap Ophthalmic Solution (0.25%)
Drug research

Reproxalap Ophthalmic Solution (0.25%)

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye DiseaseNCT04735393ALDXPhase 3Completed2022-10-11Actual
A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye DiseaseNCT05424549ALDXPhase 2Completed2022-05-09Actual
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye DiseaseNCT03404115ALDXPhase 2Completed2018-07-11Actual
The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic ConjunctivitisNCT05234554ALDXPhase 3Completed2023-04-22Actual
The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseNCT04674358ALDXPhase 2, Phase 3Completed2021-09-12Actual
A Clinical Trial to Assess Subjects With Dry Eye Disease.NCT04971031ALDXPhase 2Completed2021-09-08Actual
The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseNCT05062330ALDXPhase 3Completed2022-03-04Actual
An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease ChamberNCT05102409ALDXPhase 2Completed2021-10-25Actual
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye DiseaseNCT06389214ALDXPhase 3Completed2024-06-11Actual
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisNCT03494504ALDXPhase 3Completed2018-11-05Actual
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye DiseaseNCT06493604ALDXPhase 3Completed2025-02-27Actual
The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.NCT04207736ALDXPhase 3Completed2021-02-16Actual

Regulatory dates and decisions

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.